17/12/2024 – AB Science provides a summary of the webcast held on December 16, 2024 Download PDF Post navigationPreviousPrevious post:AB Science webcast of December 16, 2024NextNext post:AB Science will participate in the Biomed Forum investors conferenceRelated PostsSummary of the webcast held on January 28, 202529 January 2025AB Science webcast of December 16, 202416 December 2024Live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET11 December 2024AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease28 October 2024AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS17 October 2024Revenues for the first half of 2024 and update on AB Science’s activities10 October 2024
AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease28 October 2024
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS17 October 2024
